Interestingly, tau-deficient mice overexpressing GSK3β displayed reduced neurodegenerative symptoms and milder cognitive deficits, suggesting that the interaction between GSK3β and tau is critical for tau hyperphosphorylation and the development of AD [161]. The gene discussed is MAPT; the disease is Alzheimer disease.